Last Updated: 19 Sep 2024
Executive Summary
Mangoceuticals, Inc. (MGRX) is a men's wellness company that has been experiencing financial challenges. Despite a modest revenue increase, the company continues to operate at a loss. Key financial metrics such as EBITDA, EPS, and profit margin remain negative. The stock price has declined significantly in the past year, reflecting the company's ongoing struggles.
Company Overview
Mangoceuticals focuses on developing and selling men's wellness products and services through a telemedicine platform. The company's products include supplements, skincare, and sexual health treatments. Mangoceuticals is headquartered in Dallas, Texas.
Fundamental Analysis
Revenue: Revenue has increased slightly in recent quarters, but the company remains unprofitable. Revenue for the last twelve months (TTM) was $866,790.
Earnings: Mangoceuticals has been consistently reporting losses. Diluted EPS for the TTM was -$0.43.
Profitability: The company's profit margin is negative, indicating that it is not generating enough revenue to cover its expenses. Operating margin for the TTM was -13.05%.
Valuation: Based on the latest stock price of $0.24, Mangoceuticals has a market capitalization of $7,389,700. The company's price-to-sales ratio (TTM) is 8.53, which is relatively high for a company with negative earnings.
Technical Analysis
Trend: The stock price has been in a downtrend for the past year.
Support and Resistance: Key support levels are at $0.143 (52-week low) and $0.20. Key resistance levels are at $0.32 (200-day moving average) and $0.50.
Indicators: Technical indicators such as the moving averages and the relative strength index (RSI) are bearish, indicating that the stock is likely to continue to decline in the short term.
Short Term Outlook
Based on the technical analysis, the stock price is likely to continue to decline in the short term. The company's financial performance remains weak, and there are no significant catalysts on the horizon.
Long Term Outlook
The long-term outlook for Mangoceuticals is uncertain. The company needs to improve its financial performance and develop a sustainable business model. If the company can execute on its plans, the stock price could rebound in the long term. However, given the current challenges, investors should be cautious about investing in Mangoceuticals.
Analyst Recommendations
There are currently no analyst recommendations for Mangoceuticals.
